5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi

Journal of Dermatological Science

Volumn 73, Issue 2, 2014, Pages 161-163

  Uchiyama, Ryuhei ^a   Uhara, Hisashi ^a   Uchiyama, Aya ^a   Ogawa, Eisaku ^a   Takazawa, Yuko ^a   Ashida, Atsuko ^a   Koga, Hiroshi ^a   Hayashi, Koichi ^a   Kiniwa, Yukiko ^a   Okuyama, Ryuhei ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 Hydroxymethylcytosine; Biomarker; Epigenetics; Melanoma

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; TUMOR MARKER;

CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DNA METHYLATION; DNA MODIFICATION; DYSPLASTIC NEVUS; EPIGENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; LETTER; MELANOCYTIC NEVUS; MELANOMA; MOLECULAR DIAGNOSIS; NONHUMAN; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

5-HYDROXYMETHYLCYTOSINE; BIOMARKER; EPIGENETICS; MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CPG ISLANDS; CYTOSINE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; KERATINOCYTES; MALE; MELANOMA; MIDDLE AGED; NEVUS, EPITHELIOID AND SPINDLE CELL; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 84891659302     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.09.008     Document Type: Letter

References (9)

1. Wu H., D'Alessio A.C., Ito S., Wang Z., Cui K., Zhao K., et al. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev 2011, 25:679-684.
2. Haffner M.C., Chaux A., Meeker A.K., Esopi D.M., Gerber J., Pellakuru L.G., et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011, 2:627-637.
3. Yang H., Liu Y., Bai F., Zhang J.Y., Ma S.H., Liu J., et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013, 32:663-669.
4. Lian C.G., Xu Y., Ceol C., Wu F., Larson A., Dresser K., et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012, 150:1135-1146.
5. Curtin J.A., Fridlyand J., Kageshita T., Patel H.N., Busam K.J., Kutzner H., et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005, 353:2135-2147.
6. Gambichler T., Sand M., Skrygan M. Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma. Melanoma Res 2013, 23:218-220.
7. Kapur P., Selim M.A., Roy L.C., Yegappan M., Weinberg A.G., Hoang M.P. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod Pathol 2005, 18:197-204.
8. Al Dhaybi R., Sartelet H., Powell J., Kokta V. Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis. Mod Pathol 2010, 23:376-380.
9. Conway K., Edmiston S.N., Khondker Z.S., Groben P.A., Zhou X., Chu H., et al. DNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Res 2011, 24:352-360.